208 related articles for article (PubMed ID: 6153156)
1. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis.
Waxman FJ; Fritz RB; Hinrichs DJ
Cell Immunol; 1980 Jan; 49(1):34-42. PubMed ID: 6153156
[No Abstract] [Full Text] [Related]
2. Experimental allergic encephalomyelitis in the guinea pig: variation in peripheral blood lymphocyte responsiveness to myelin basic protein during disease development.
Lyman WD; Kadish AS; Raine CS
Cell Immunol; 1981 Sep; 63(2):409-16. PubMed ID: 6168397
[No Abstract] [Full Text] [Related]
3. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
Ben-Nun A; Cohen IR
J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
[No Abstract] [Full Text] [Related]
4. Durability of immune protection against experimental autoimmune encephalomyelitis.
Bernard CC; Mackay IR; Whittingham S; Brous P
Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
[No Abstract] [Full Text] [Related]
5. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.
McGraw TP; Swanborg RH
Eur J Immunol; 1978 Dec; 8(12):905-9. PubMed ID: 365547
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
7. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
[No Abstract] [Full Text] [Related]
8. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis.
Willenborg DO; Sjollema P; Danta G
J Neuroimmunol; 1986 Apr; 11(2):93-103. PubMed ID: 2419359
[TBL] [Abstract][Full Text] [Related]
9. Cellular and genetic basis of the relative resistance to the induction of experimental allergic encephalomyelitis (EAE) in albino oxford (AO) rats.
Mostarica-Stojkovic M; Petrovic M; Lukic ML
Adv Exp Med Biol; 1982; 149():699-702. PubMed ID: 6216773
[No Abstract] [Full Text] [Related]
10. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
[TBL] [Abstract][Full Text] [Related]
11. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
Willenborg DO; Higgins TJ
Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
[TBL] [Abstract][Full Text] [Related]
12. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
[No Abstract] [Full Text] [Related]
13. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
Killen JA; Swanborg RH
J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
[TBL] [Abstract][Full Text] [Related]
14. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
MacPhee IA; Mason DW
J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
[TBL] [Abstract][Full Text] [Related]
15. Participation of encephalitogen in incomplete Freund's adjuvant in the induction of experimental allergic encephalomyelitis in Hartley guinea pigs.
Lebar R; Vincent C
J Neuroimmunol; 1984 Jun; 6(3):187-96. PubMed ID: 6202714
[TBL] [Abstract][Full Text] [Related]
16. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
Welch AM; Holda JH; Swanborg RH
J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
[TBL] [Abstract][Full Text] [Related]
17. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
Holda JH; Swanborg RH
Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
[TBL] [Abstract][Full Text] [Related]
18. Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease.
Schaecher K; Rocchini A; Dinkins J; Matzelle DD; Banik NL
J Neuroimmunol; 2002 Aug; 129(1-2):1-9. PubMed ID: 12161014
[TBL] [Abstract][Full Text] [Related]
19. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
Welch AM; Swierkosz JE; Swanborg RH
J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
[No Abstract] [Full Text] [Related]
20. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
Willenborg DO
J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
